文献速递胸部技术与安全US

肺超声在COVID-19感染低流行区非住院疑似病例中检测早期胸膜与肺病变的价值:一项297例受试者的前瞻性研究

The Value of Lung Ultrasound to Detect the Early Pleural and Pulmonary Pathologies in Nonhospitalized COVID-19-Suspected Cases in a Population With a Low Prevalence of COVID-19 Infection: A Prospective Study in 297 Subjects.
PubMed 文献 · J Ultrasound Med · 2021-09-04

2020年4月至6月在一家门诊COVID-19疑似病例检测中心,297例受试者在鼻咽拭子RT-PCR前接受B型肺超声检查。RT-PCR阳性11例、阴性286例,感染患病率3.7%;肺超声检出病理表现56/297(18.9%),识别COVID-19感染的敏感度27.3%、特异度81.5%、阳性预测值5.4%、阴性预测值96.7%、诊断准确率79.9%。作者认为肺超声诊断性能低,不能作为该人群的充分诊断方法。

要点

  • 低流行区非住院疑似人群中COVID-19患病率仅3.7%(11/297),肺超声阳性预测值5.4%。
  • 肺超声识别COVID-19感染敏感度27.3%、特异度81.5%、准确率79.9%。
  • 肺超声病理表现见于56/297(18.9%)受试者,包括胸腔积液、B线、脏层胸膜碎裂、实变及实变内空气支气管征。

核心结论

  • 肺超声识别COVID-19感染的诊断性能高度依赖患者谱和疾病患病率;在低流行区非住院COVID-19病例中诊断性能低,不能视为该人群的充分诊断方法。

研究设计与样本

  • 前瞻性研究,纳入2020年4月至6月门诊COVID-19疑似病例检测中心的297例受试者,在鼻咽拭子RT-PCR前行B型肺超声检查,以RT-PCR结果为参考标准。

关键影像表现/征象

  • 肺超声病理表现定义为:胸腔积液、B线、脏层胸膜碎裂、实变、实变内空气支气管征;56/297(18.9%)受试者检出至少一项病理表现。

诊断标准与关键数值

  • 肺超声识别COVID-19感染:敏感度27.3%、特异度81.5%、阳性预测值5.4%、阴性预测值96.7%、诊断准确率79.9%;RT-PCR阳性11例、阴性286例,患病率3.7%。

临床应用与阅片要点

  • 作者认为,由于在低流行区非住院COVID-19病例中诊断性能低,肺超声不能作为该人群的诊断方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This prospective study aimed to evaluate the value of B-mode lung ultrasound (LUS) for the early diagnosis of coronavirus disease 2019 (COVID-19) infection in nonhospitalized COVID-19 suspected cases in a population with a low prevalence of disease.

METHODS: From April 2020 to June 2020, in an ambulatory testing center for COVID-19-suspected cases, 297 subjects were examined by LUS before a nasopharyngeal swab was taken for a reverse transcription polymerase chain reaction (RT-PCR) test. The following LUS findings were defined as pathological ultrasound findings and were analyzed: the presence of 1) pleural effusion, 2) B-lines, 3) fragmented visceral pleura, 4) consolidation, and 5) air bronchogram in the consolidation. The LUS findings were compared with the RT-PCR test results.

RESULTS: The result of the RT-PCR test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive in 11 and negative in 286 subjects, and the prevalence of COVID-19 infection in the study participants was 3.7%. On LUS, a pathological finding could be detected in 56/297 (18.9%) study participants. The LUS revealed a sensitivity of 27.3%, a specificity of 81.5%, a positive predictive value of 5.4%, a negative predictive value of 96.7%, and a diagnostic accuracy of 79.9% for the identification of COVID-19 infection.

CONCLUSIONS: For the identification of COVID-19 infection, LUS is highly sensitive to the patient spectrum and to the prevalence of the disease. Due to the low diagnostic performance in nonhospitalized COVID-19 cases in low-prevalence areas, LUS cannot be considered to be an adequate method for making a diagnosis in this group.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Safai Zadeh E, Huber KP, Dietrich CF, et al. The Value of Lung Ultrasound to Detect the Early Pleural and Pulmonary Pathologies in Nonhospitalized COVID-19-Suspected Cases in a Population With a Low Prevalence of COVID-19 Infection: A Prospective Study in 297 Subjects. J Ultrasound Med. 2021. PMID: 34480772. doi:10.1002/jum.15822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。